Bounded definition
A comparison boundary between immortalized or transformed model cells and donor-derived primary cells with different chromatin, state, and handling.
What the cited work establishes
The study develops an in-vitro circularized-DNA assay for Cas9 activity and compares nominations with cellular activity and genomic context for specified targets.
The constructs, biological systems, protocols, assays, datasets, and comparisons reported in CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity.
Claims: urn:maha:claim:cell-line-versus-primary-cell-evidence
What remains a separate question
Results from a transformed line cannot be silently relabeled as performance in primary cells, and donor variation remains a separate uncertainty source.
In-vitro nomination is not identical to editing frequency or biological consequence in a treated cell population or organism.
Connected domain graph
Typed dependencies preserve publication state.
Only independently canonical records receive public links and relation statements. Draft graph topology remains private.
Ex-vivo genome-editing workflow
inbound connection · method
The cell product is composed of participant-derived primary cells, not an immortalized line.
In-vitro versus in-vivo evidence
outbound connection · comparison
Primary-cell evidence remains distinct from organism-level exposure and response.
Claim ledger
Every proposition keeps its own evidence state.
The cited study measures and compares off-target activity and genomic context in therapeutically relevant loci and primary human T-cell experiments.
- Scope
- The constructs, biological systems, protocols, assays, datasets, and comparisons reported in CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity.
- Boundary
- Results from a transformed line cannot be silently relabeled as performance in primary cells, and donor variation remains a separate uncertainty source.
- Uncertainty
- There is no universal effect estimate for this method; numerical results remain attached to the source experiment, biological system, assay, and analysis choices.
- Replication
- This candidate records one bounded source package. Independent replications and contradictory results must be compiled separately before evidence maturity is upgraded.
Primary sources
Citation, locator, rights, and boundary travel together.
Source 1 · Nature Biotechnology
CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity
Christopher R. Lazzarotto, Nhu T. Nguyen, J. A. Tangprasertchai, S. C. Malagon-Lopez, et al.
- Exact locator
- Abstract; Figures 1–6; Methods; datasets PRJNA625995 and GSE149295.
- Establishes
- The study develops an in-vitro circularized-DNA assay for Cas9 activity and compares nominations with cellular activity and genomic context for specified targets.
- Boundary
- In-vitro nomination is not identical to editing frequency or biological consequence in a treated cell population or organism.
- Rights basis
- citation with paraphrase · Maha paraphrases the source-level result and links to the version of record; no article passage is reproduced.
- Declared interests
- The article declares patent and company relationships involving genome-editing assays and therapeutics.